Effects of communicating individual risks in screening programmes: Cochrane systematic review

Effects of communicating individual risks in screening programmes: Cochrane systematic review
复制标题

DOI:
10.1136/bmj.327.7417.703
复制
发表时间:
2003-09-27
影响因子:
105.7
通讯作者:
Hood, K
Hood, K
中科院分区:
医学1区
文献类型:
--
作者:
Edwards, A;Unigwe, S;Hood, K

文献摘要

被引文献

相似文献

目的评估不同类型的个体化风险沟通对决定是否参加筛查的患者的影响。设计系统评价。数据来源科克伦消费者和沟通审查组的专家注册,科学数据库,研究的选择研究是随机对照试验,由患者决定是否接受筛查,并纳入一个干预与元素的“个性化”的风险沟通的基础上,个人的自身风险因素的条件(如年龄或家族史)。结果measures的主要结果是摄取的筛查测试,进一步的认知和情感的措施,也进行了评估,以衡量知情的decisionmaking. Results13项研究被列入,其中10个解决乳房X光检查程序。个体化风险沟通与筛查试验的增加相关(比值比1.5,95%置信区间1.11至2.03)。很少有认知或情感的结果一致的报告,因此,它是不可能得出结论,是否增加了测试的摄取量有关的知情决策patient.Conclusions个体化的风险估计可能是有效的人口健康的目的,但他们的影响增加摄取筛查计划可能无法解释为证据的知情决策的患者。需要更多地注意如何制定干预措施,以筛选能够实现这一目标的方案。
Objective To assess the effects of different types of individualised risk communication for patients who are deciding whether to participate in screening.Design Systematic review.Data sources Specialist register of the Cochrane consumers and communication review group, scientific databases, and a manual follow up of references.Selection of studies Studies were randomised controlled trials addressing decisions by patients whether or not to undergo screening and incorporating an intervention with an element of "individualised" risk communication-based on the individual's own risk factors for a condition (such as age or family history).Outcome measures The principal outcome was uptake of screening tests; further cognitive and affective measures were also assessed to gauge informed decision making.Results 13 studies were included, 10 of which addressed mammography programmes. Individualised risk communication was associated with an increased uptake of screening tests (odds ratio 1.5, 95% confidence interval 1.11 to 2.03). Few cognitive or affective outcomes were reported consistently, so it was not possible to conclude whether this increase in the uptake of tests was related to informed decision making by patients.Conclusions Individualised risk estimates may be effective for purposes of population health, but their effects on increasing uptake of screening programmes may not be interpretable as evidence of informed decision making by patients. Greater attention is required to ways of developing interventions for screening programmes that can achieve this.